Cryolife Inc  

(Public, NYSE:CRY)   Watch this stock  
Find more results for ASHLEY M. CAPPS�
10.04
+0.01 (0.10%)
Aug 29 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 9.95 - 10.13
52 week 6.01 - 12.14
Open 10.04
Vol / Avg. 43,044.00/123,386.00
Mkt cap 280.37M
P/E 18.76
Div/yield 0.03/1.20
EPS 0.54
Shares 27.93M
Beta 1.29
Inst. own 59%
Oct 27, 2014
Q3 2014 CryoLife Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Aug 13, 2014
CryoLife Inc at Canaccord Genuity Growth Conference
Jul 24, 2014
Q2 2014 CryoLife Inc Earnings Call - Webcast
Jul 24, 2014
Q2 2014 CryoLife, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 6.23% 11.49%
Operating margin 6.41% 7.52%
EBITD margin - 13.97%
Return on average assets 4.99% 9.75%
Return on average equity 5.84% 11.58%
Employees 510 -
CDP Score - -

Address

STE 142, 1655 ROBERTS BOULEVARD N W
KENNESAW, GA 30144
United States - Map
+1-770-4193355 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

CryoLife, Inc. (CryoLife,) is a biological medical device company. The Company preserves and distributes human tissues for transplantation and develops, manufactures, and commercializes medical devices for cardiac and vascular applications. The Company operates in two segments: preservation services and medical devices segment. The preservation services segment includes services revenues from the preservation of cardiac and vascular tissues during the year ended December 31, 2011. The medical devices segment includes revenues from product sales of BioGlue, BioFoam, PerClot, HemoStase and revascularization technologies, as well as sales of other medical devices.In August 2014, the Company acquired distribution rights to PhotoFix, a bovine pericardial patch stabilized using a dye-mediated photo-fixation process that requires no glutaraldehyde from Genesee BioMedical, Inc., a Denver, Colorado-based manufacturer of cardiac surgery instruments and devices.

Officers and directors

Steven G. Anderson Executive Chairman of the Board
Age: 75
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
D. Ashley Lee CPA Chief Financial Officer, Chief Operating Officer, Executive Vice President
Age: 49
Bio & Compensation  - Reuters
David P. Lang Senior Vice President - International Sales and Marketing
Age: 67
Bio & Compensation  - Reuters
Bruce G. Anderson Vice President - U.S. Sales and Marketing
Age: 47
Bio & Compensation  - Reuters
Scott B. Capps Vice President - Clinical Research
Age: 47
Bio & Compensation  - Reuters
David M. Fronk Vice President - Regulatory Affairs and Quality Assurance
Age: 50
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
David C. Gale Ph.D. Vice President - Research & Development
Age: 46
Bio & Compensation  - Reuters
Jon W. Salveson Director
Age: 49
Bio & Compensation  - Reuters
Thomas F. Ackerman Independent Director
Age: 59
Bio & Compensation  - Reuters
James S. Benson Independent Director
Age: 74
Bio & Compensation  - Reuters